OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic-Associated Fatty Liver Disease and Sarcopenia
Triada Bali, Lampros Chrysavgis, Εvangelos Cholongitas
Endocrinology and Metabolism Clinics of North America (2023) Vol. 52, Iss. 3, pp. 497-508
Closed Access | Times Cited: 10

Showing 10 citing articles:

Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
Xuanyu Hao, Kai Zhang, Xingyong Huang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 7, pp. 636-643
Open Access | Times Cited: 7

Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
Saori Onishi, Akira Fukuda, Masahiro Matsui, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3878-3878
Open Access | Times Cited: 14

Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes
Qian Wang, Huiyi Chen, Huiling Deng, et al.
Diabetes & Metabolism (2025), pp. 101628-101628
Closed Access

Sarcopenia and non-alcoholic fatty liver disease - complex pathogenetic relationships
В. А. Ахмедов, V. S. Marinenko
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 110-118
Closed Access

The association of testosterone with sarcopenia and frailty in chronic liver disease
Lampros Chrysavgis, Magdalini Adamantou, Anna Angelousi, et al.
European Journal of Clinical Investigation (2023) Vol. 54, Iss. 2
Open Access | Times Cited: 8

Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature
Lampros Chrysavgis, Spyridon Kazanas, Konstantina Bafa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3832-3832
Open Access | Times Cited: 2

Metabolic Syndrome and Its Impact on Bone and Joint Health: A Comprehensive Review
Abhishek Vaish, Raju Vaishya, Karthikeyan P. Iyengar
Apollo Medicine (2024)
Closed Access | Times Cited: 2

Metabolic Dysfunction-associated Fatty Liver Disease: An Urgent Call for Global Action
Cornelius James Fernandez, Lakshmi Nagendra, Joseph M Pappachan
touchREVIEWS in Endocrinology (2023) Vol. 20, Iss. 1, pp. 1-1
Open Access | Times Cited: 2

Page 1

Scroll to top